-transparent.png){kind=logo}
A sensitive assay for human plasma BzAO, involving the conversion of 14C-benzylamine to 14C-benzaldehyde, was developed. MPTP and several of its analogues were found to be competitive inhibitors of the enzyme. Ki values for the MPTP analogues in the presence of human plasma BzAO were determined. The analogues had a different rank order of inhibition of human plasma BzAO compared with the rank order of inhibition of bovine plasma BzAO found previously. MPTP and 1-methyl-4-(2-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP), which are potent nigrostriatal toxins, were weak inhibitors of human plasma BzAO.
Related Publications
A J Devlin, and
A R Bhatti, and
A C Williams, and
D B Ramsden
October 1986,
Neuroscience letters,
A J Devlin, and
A R Bhatti, and
A C Williams, and
D B Ramsden
December 1985,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A J Devlin, and
A R Bhatti, and
A C Williams, and
D B Ramsden
January 1996,
Parkinsonism & related disorders,
A J Devlin, and
A R Bhatti, and
A C Williams, and
D B Ramsden
May 1986,
Neuroscience letters,
A J Devlin, and
A R Bhatti, and
A C Williams, and
D B Ramsden
April 1989,
Sheng li ke xue jin zhan [Progress in physiology],
A J Devlin, and
A R Bhatti, and
A C Williams, and
D B Ramsden
December 1986,
The Biochemical journal,
A J Devlin, and
A R Bhatti, and
A C Williams, and
D B Ramsden
March 1986,
Journal of medicinal chemistry,
A J Devlin, and
A R Bhatti, and
A C Williams, and
D B Ramsden
March 1991,
Toxicology,
A J Devlin, and
A R Bhatti, and
A C Williams, and
D B Ramsden
November 1990,
Brain research,
A J Devlin, and
A R Bhatti, and
A C Williams, and
D B Ramsden
February 1987,
Toxicology,
